ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 581,88
-0,67%
Dow Jones
40 211,72
0,53%
DAX
18 496,83
-0,56%
Brent Oil
83,635
-0,84%
Bitcoin
62 664,47
-3,37%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Hutchison China Meditech Ltd (0J7G)

  7. Hutchison China Meditech Ltd (0J7G) Actualités

0J7G

Hutchison China Meditech (0J7G)

Hutchison China Meditech Ltd
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0J7G
DateHeureSourceTitreSymboleSociété
31/03/202008h04RNS Non-RegulatoryHutchison China Meditech Limited China Phase II trial initiation in mesotheliomaLSE:0J7GHutchison China Meditech Ltd
25/03/202008h00UK RegulatoryHutchison China Meditech Limited Annual Financial ReportLSE:0J7GHutchison China Meditech Ltd
09/03/202008h00UK RegulatoryHutchison China Meditech Limited Vesting of awards under Long Term Incentive PlanLSE:0J7GHutchison China Meditech Ltd
03/03/202015h18RNS Non-RegulatoryHutchison China Meditech Limited Form-20F PublicationLSE:0J7GHutchison China Meditech Ltd
03/03/202013h15UK RegulatoryHutchison China Meditech Limited Final Results and Clinical UpdateLSE:0J7GHutchison China Meditech Ltd
25/02/202008h00UK RegulatoryHutchison China Meditech Limited Notice of ResultsLSE:0J7GHutchison China Meditech Ltd
10/02/202008h00RNS Non-RegulatoryHutchison China Meditech Limited Phase II Savolitinib / Imfinzi® Combination DataLSE:0J7GHutchison China Meditech Ltd
06/02/202017h35UK RegulatoryHutchison China Meditech Limited Price Monitoring ExtensionLSE:0J7GHutchison China Meditech Ltd
06/02/202008h20UK RegulatoryHutchison China Meditech Limited Issue of EquityLSE:0J7GHutchison China Meditech Ltd
04/02/202017h40UK RegulatoryHutchison China Meditech Limited Second Price Monitoring ExtnLSE:0J7GHutchison China Meditech Ltd
29/01/202008h25UK RegulatoryHutchison China Meditech Limited Holding(s) in CompanyLSE:0J7GHutchison China Meditech Ltd
23/01/202008h35UK RegulatoryHutchison China Meditech Limited Pricing of US$110 Million Public Offering of ADSsLSE:0J7GHutchison China Meditech Ltd
22/01/202008h00UK RegulatoryHutchison China Meditech Limited Chi-Med Announces Proposed Offering of ADSsLSE:0J7GHutchison China Meditech Ltd
20/01/202011h40UK RegulatoryHutchison China Meditech Limited Positive SANET-p Phase III Clinical Trial ResultsLSE:0J7GHutchison China Meditech Ltd
13/01/202008h00RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Starts Surufatinib+PD-1 Ph2 Combo TrialLSE:0J7GHutchison China Meditech Ltd
06/01/202008h04RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med to Present at JP Morgan ConferenceLSE:0J7GHutchison China Meditech Ltd
31/12/201908h00UK RegulatoryHutchison China Meditech Limited Block Listing Six Monthly ReturnLSE:0J7GHutchison China Meditech Ltd
31/12/201908h00UK RegulatoryHutchison China Meditech Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
20/12/201908h00RNS Non-RegulatoryHutchison China Meditech Limited Surufatinib Granted Priority Review in ChinaLSE:0J7GHutchison China Meditech Ltd
12/12/201909h57UK RegulatoryHutchison China Meditech Limited Grant of share optionsLSE:0J7GHutchison China Meditech Ltd
28/11/201908h01RNS Non-RegulatoryHutchison China Meditech Limited Elunate® Included in China NRDLLSE:0J7GHutchison China Meditech Ltd
25/11/201908h47RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Highlights Presentations at 2019 ESMO AsiaLSE:0J7GHutchison China Meditech Ltd
25/11/201908h01RNS Non-RegulatoryHutchison China Meditech Limited Surufatinib granted FDA orphan drug designationLSE:0J7GHutchison China Meditech Ltd
11/11/201908h00RNS Non-RegulatoryHutchison China Meditech Limited Surufatinib China NDA acceptanceLSE:0J7GHutchison China Meditech Ltd
17/10/201908h26RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Ph II gastric cancer data for SavolitinibLSE:0J7GHutchison China Meditech Ltd
10/10/201911h22UK RegulatoryHutchison China Meditech Limited Grant of share options under share option schemeLSE:0J7GHutchison China Meditech Ltd
10/10/201910h00RNS Non-RegulatoryHutchison China Meditech Limited Innovent and Chi-Med Expand Global CollaborationLSE:0J7GHutchison China Meditech Ltd
04/10/201908h11RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Phase I/Ib Trial of HMPL-523 in LymphomaLSE:0J7GHutchison China Meditech Ltd
30/09/201908h03RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Surufatinib Phase III data at ESMOLSE:0J7GHutchison China Meditech Ltd
25/09/201908h01RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Presents SANET-ep Phase III data at ESMOLSE:0J7GHutchison China Meditech Ltd
 Showing the most relevant articles for your search:LSE:0J7G

Dernières Valeurs Consultées

LSE
0RA9
Abivax
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés